Skip to main content

October 31, 2014 03:33:00 PMCreating Connections in Cape Town
South African health minister Aaron Motsoaledi, hobbling with his foot in a boot, arrived this morning in Cape Town after flying overnight from a lung health congress in Barcelona.
Written by  Guest Blogger 
Category:   | No  Comments |   Links to this post
October 31, 2014 03:01:00 PMFirst Study Results of Passive Antibody Transfer Spur Future Planning
Following positive initial results from Phase I safety trials evaluating direct administration of VRC01, an HIV-specific antibody that is able to neutralize a broad variety of HIV strains, the National Institute of Allergy and Infectious Diseases (NIAID) is preparing for a series of further studies to see if this broadly neutralizing antibody is effective in preventing transmission of HIV from mothers to their infants, as well as among high-risk adults.
Written by  Guest Blogger 
Category:   | No  Comments |   Links to this post
October 30, 2014 04:04:00 PMAntibodies Meet Microbicides
Using a laboratory model made from post-surgery cervical and colo-rectal human tissue, researchers at the University of Pittsburgh Graduate School of Public Health are seeing positive initial results in HIV prevention by adding powerful antibodies to a topical gel.
Written by  Guest Blogger 
Category:   | No  Comments |   Links to this post
October 30, 2014 12:12:00 PMWith HIV Prevention Possibilities on the Rise, an African Cohort Closes in on a Last Checkup
Several years ago, a group of 613 people recently infected with HIV from Uganda, Rwanda, Zambia, Kenya, and South Africa volunteered for a scientific study group led by the International AIDS Vaccine Initiative (IAVI). This extensive study became known as Protocol C and is the largest acute infection cohort in Africa.
Written by  Guest Blogger 
Category:   | No  Comments |   Links to this post
October 29, 2014 03:17:00 PMTackling Stigma in South Africa
Every market needs an index to benchmark itself. In South Africa they’re setting one to measure public attitudes of intolerance and stigma toward people living with HIV and AIDS.
Written by  Guest Blogger 
Category:   | No  Comments |   Links to this post
October 29, 2014 10:54:00 AMMicrobicide and Vaccine, Sidekicks at Last?
Results from an initial study combining a microbicide candidate and experimental vaccine are promising enough to at least keep Imperial College virologist Robin Shattock coming back for more in pursuing what could be a novel move in preventing HIV infection.
Written by  Guest Blogger 
Category:   | No  Comments |   Links to this post
October 29, 2014 10:46:00 AMMuscle-flexing in Cape Town (with a Smile)
With an incidence of HIV in one hard-hit region of South Africa reaching 44 percent among young pregnant mothers, this part of the world is on the front lines of the public health response to HIV. At the HIV R4P conference in Cape Town on Tuesday, however, South African science minister Naledi Pandor wanted to let the world know her country was no longer a passive participant, content to supply trial volunteers while others did the research.
Written by  Guest Blogger 
Category:   | No  Comments |   Links to this post
October 29, 2014 10:42:00 AMVaccine from Thailand Shows Promise in South Africa

Glenda Gray, executive director of the Wits Health Consortium in South Africa, presented data today at the HIV R4P conference in Cape Town indicating that the prime-boost vaccine candidates initially tested in the RV144 trial in Thailandcross-clade immune responses in a Phase I safety trial conducted in South Africa, with immunogenicity similar to or greater than that of the responses induced in Thai volunteers.

Written by  Guest Blogger 
Category:   | No  Comments |   Links to this post
October 28, 2014 11:30:00 AMBringing Prevention Communities Together in Cape Town
HIV R4P organizers carry high hopes for the first conference attempting to knit together all HIV prevention efforts, says conference co-chair, Sharon Hillier, a University of Pittsburgh professor of obstetrics, gynecology, molecular genetics, and biochemistry.
Written by  Guest Blogger 
Category:   | No  Comments |   Links to this post
October 28, 2014 11:17:00 AMHIV R4P Shadowed by Ebola
As the inaugural HIV R4P conference gets underway in Cape Town, South Africa, the first virus everyone is talking about isn’t HIV. Discussions in the hallways and over coffee start off with another virus: Ebola.
Written by  Guest Blogger 
Category:   | No  Comments |   Links to this post
 Next >>